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Abstract
Type of feeding during early life influences growth trajectory and metabolic risk at later ages. Modifications in infant formula composition have
led to evaluate their effects on growth and energetic efficiency (EE) compared with breast-feeding. Main goal was to analyse type of feeding
potential effects during first months of life, plus its EE, on growth patterns in healthy formula fed (standard infant formula (SF) vs. experimental
infant formula enriched with bioactive nutrients (EF)) and breastfed (BF) infants participating in the COGNIS RCT (www.ClinicalTrials.gov,
Identifier: NCT02094547) up to 18 months of age. Infants follow-up to 18 months of age (n 141) fed with a SF (n 48), EF(n 56), or BF (n
37), were assessed for growth parameters usingWHO standards. Growth velocity (GV) and catch-upwere calculated to identify growth patterns.
EE of breast milk/infant formula was also estimated. Infants’ growth at 6months showed higher length and lower head circumference gains in SF
and EF infants than BF infants. Both weight-for-length and weight-for-age catch-up growth showed significant differences in formula fed groups
compared with the BF. No significant differences in GV or catch-up were found at 6–12 and 12–18 months. Regarding EE, infant formula groups
showed significantly lowerweight and length gains/g ofmilk protein, and higherweight and length gains/g ofmilk lipids, than the BF infants. GV
during first 6 months, which may be influenced by feeding, seems to be the main predictor of subsequent growth trajectory. Breast-feeding may
have positive effects on growth programming due to its nutrients’ EE.
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Type of feeding after birth has been associated with growth
velocity (GV) during the first years of life and may determine
growth during childhood and adolescence. Both weight gain
during the first 2 years of life and differences in weight-for-age
z-score (WAZ) indicator could define child growth pattern(1,2).
Different authors have described a rapid growth pattern in
infants associated with higher risk of obesity(1,3–6), type 2 diabe-
tes and CVD later on(7–10).
TheWHO recommends exclusive breast-feeding (BF) during
the first 6months of life, continuing at least until 24months of age
along with complementary feeding(11,12). Infant formulas intent
to promote an adequate growth, neurodevelopment and health
programming in infants, when breast-feeding is not possible(13).
However, feeding with infant formulas has been shown to
increase weight gain and BMI during the first year of life(14,15),
compared with breast milk.
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During last years, infant formulas have been modified and
enriched with bioactive ingredients similar to those present in
human milk to provide the necessary amount of energy and
nutrients to reach an optimal growth(16). Both the protein and lipid
fractions of bovine milk fat globule membrane(17–20), long-chain
PUFAs (arachidonic acid, DHA, etc.)(21,22), synbiotics (probiotics
and prebiotics)(23,24), sialic acid and milk oligosaccharides(25,26)
have been added to infant formulas as an alternative to narrow
the nutritional and functional gap compared with breast milk.
Furthermore, protein content modification(27) and infant formula
supplementationwith different nutrients have been studied to iden-
tify their effects on energetic efficiency (EE)(28,29), growth, develop-
ment and immune function compared with breast-feeding(13,30).
To date, numerous studies have been focused on the effects of
enriched infant formulas on growth rates, obesity risk associated
with protein intake at early ages and benefits of the fatty acid pro-
file or other nutrients in childhood neurodevelopment(12,31–33).
Nevertheless, there is insufficient scientific evidence about the
effect of bioactive compounds-enriched infant formulas on infant
growth trajectory(30). Having in mind these considerations, the
present study was aimed to analyse the potential effects of the
type of feeding during the first months of life, as well as its EE,
on growth patterns in healthy formula fed (standard v. enriched
infant formula) and breastfed (BF) infants up to 18 months of age.
Methods
The present study was carried out following the updated
Declaration of Helsinki Principles(34,35), the Good Clinical
Practice recommendations of the ECC (document 111/3976/88
July 1990) and Spanish Royal Decree 561/1993 on clinical trials.
All procedures involved in the COGNIS study were approved by
the Research Bioethical Committee from the University of
Granada, as well as the Bioethical Committees for Clinical
Research of San Cecilio and Mother-Infant Hospitals of
Granada. All families were informed about protocols and a
signed written consent was obtained from each parent or legal
guardian before involving each child in the study.
Study design and subjects
The COGNIS study (registered at www.ClinicalTrials.gov,
Identifier: NCT02094547) is a prospective, double-blind rando-
mised clinical trial (RCT) with a nutritional intervention using
a new infant formula enriched with bioactive nutrients such as
milk fat globule membrane components (10 % of total protein
(wt:wt)), long-chain PUFAs (DHA and arachidonic acid), synbi-
otics (mix of fructooligosaccharide and inulin (ratio 1:1),
Bifidobacterium infantis IM1 and Lactobacillus rhamnosus
LCS-742), nucleotides, sialic acid and ganglioside-enriched
whey proteins.
Inclusion criteria. Eligible infants were healthy term infants
(37–41 weeks gestational age), with adequate birth weight for
gestational age (between 3–97 percentile), normal APGAR score
(7–10) and umbilical pH≥ 7·10. They must have availability to
continue throughout the study period, and parents or legal
guardians have signed the informed consent.
Exclusion criteria. The exclusion criteria were defined as follows:
infants participating in another study; infantswho sufferedneurologi-
cal disorders (hydrocephalus, perinatal hypoxia, intraventricular
haemorrhage, neonatal meningitis, septic shock, West syndrome,
etc.) or gastrointestinal disturbances (mainly cows’ milk protein
allergy/intolerance or lactose intolerance); maternal pathological
background (neurological diseases, mental illness, metabolopathies
(type 1 diabetes mellitus), chronic diseases (hypothyroidism), mater-
nalmalnutritionorprenatal infections (TORCHcomplex, etc.)),moth-
ers who received during pregnancy or lactation drug treatments
potentially harmful for neurodevelopment (anxiolytics, anti-
depressants, etc.); parents impossibility to continue through the
study. A detailed description of the COGNIS study can be found
in online Supplementary Methods. Briefly, a total of 220 full-term
infants were enrolled, 170 of them were randomised (ratio 1:1) to
receive, during their first 18 months of life, either a standard infant
formula (SF; n 85) or an experimental infant formula (EF; n 85)
enrichedwith bioactive nutrients. A total of fifty exclusively breastfed
(BF) infants for at least 2 months were also included as reference
group. The present study involved 171 infants at 6 months
(SF= 60; EF= 69; BF= 42); 152 infants at 12 months (SF= 51;
EF= 63; BF= 38) and 141 infants at 18 months (SF= 48; EF= 56;
BF= 37). A detailed participant flow chart from the baseline visit
to 18 months of life is shown in Fig. 1.
Demographical and clinical characteristics
Baseline information about maternal and paternal age,
anthropometric characteristics (BMI and height), as well as their
educational level, place of residence and intelligence quotient
(IQ) was obtained at study entry. Prenatal characteristics (weight
gain during pregnancy, siblings, type of delivery and smoking
during pregnancy) were also recorded. Data regarding weight,
length and head circumference (HC) at birth were taken from
clinical records.
Evaluation of infant growth patterns
To analyse the potential effects of the type of feeding on infants
growth, anthropometric measurements were collected at 1–2, 3,
4, 6, 12 and 18months of life by a trained paediatrician, following
standard procedures(36); measurements were taken in triplicate
and their means were calculated. Analyses of growth patterns
were performed by a trained nutritionist. A detailed description
of growth measurements analyses can be found in online
Supplementary Methods.
Anthropometric data included weight (SOEHNLE Multina
Comfort 8352·01·001, max 20 kg), length (Harpenden
Infantometer Holtain Model 702, max 91·5 cm) and HC (SECA
212, max 59 cm). All anthropometric parameters were assessed
according to the current WHO Child Growth Standards by sex
and age(37,38). WAZ, weight-for-length z-score (WLZ), length-
for-age z-score (LAZ), BMI-for-age z-score and HC-for-age
z-score (HCZ) were calculated using WHO Anthro software
package version 3.2.2 (WHO)(37).
GVwas calculated according toweight, length andHCgains/d.
Weight gain (g/d), length gain (cm/d) and HC (cm/d) were calcu-
lated at three different time intervals: (i) from the baseline visit
(formula fed infants groups) or from birth (BF infants) to
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6 months of life, (ii) from 6 to 12 months of life and (iii) from 12 to
18 months of life. These data were compared using velocity stan-
dards for weight, length and HC of the WHO growth standards
presented as 6-month intervals and stratifiedby sex, toobtain stan-
dard deviations (SD). GV was classified as: slow (< –1 SD), normal
(≥ –1 SD and ≤þ 1 SD) or rapid (>þ 1 SD), based on the cut-off
points indicated by WHO for the analysis of growth indicators
and the identification of growth problems (≥þ 1 SD and
≤ –1 SD)(36). After this, to identify infant growth pattern developed
up to 18 months of age, trajectories of weight, length, HC and
growth indicators WAZ, LAZ, WLZ and HCZ were analysed up
to 18 months, according to weight GV up to 6 months of age.
Catch-up growth is defined as the variation in infant weight
gain rates, which shows a significant growth to compensate from
intra-uterine restriction or enhancement of growth, during the first
2 years of life(1,3). Catch-up growth was calculated as WAZ and
WLZ. Differences in z-scores were considered as the three time
intervalsmentioned above. Afterwards, catch-up growthwas clas-
sifiedby the differences inz-scores as follows: slow (< –0·67), nor-
mal (≥ –0·67 and ≤þ 0·67) and rapid (>þ 0·67)(1,3).
Fig. 1. Dropout rates and exclusions from the baseline visit to 18 months of age. Infants who did not show up at the follow-up visits, but remained in COGNIS study for
later visits are described as ‘did not attend’. SF, standard infant formula; EF, experimental infant formula; BF, breastfed infants; EE, energetic efficiency. D = drop outs
and E = exclusions, as previously reported(41). *SF and EF infants were randomised between 0 and 2 months of age; BF infants were included up to 6 months of age.
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Estimation of breast milk/infant formula energetic
efficiency
This parameter is described as the increase in weight and length
according to the energy andmacronutrient intake (proteins, carbo-
hydrates and lipids) per day from infant formula or breastmilk(28,29).
The average of energy and macronutrients intake was obtained
using a 3-d dietary record at 6, 12 and 18 months. For the infant
formula groups, the daily volume of milk (ml) was reported as
the amount of water (ml) and powdered formula (g) for infant for-
mula reconstitution. Volume of breast milk intake (ml) was esti-
mated according to infant gastric capacity and theoretical
estimates for breast milk intake(39,40). Detailed description in this
regard is included in online Supplementary Methods. EE was
expressed as (a) weight gain (g/d)/4184 kJ (100 kcal) of milk,
(b) weight gain (g/d)/g of milk protein, (c) weight gain (g/d)/g
of milk carbohydrate, (d) weight gain (g/d)/g of milk lipids, (e)
length gain (mm/d)/418·4 kJ (100 kcal) of milk, (f) length gain
(mm/d)/g of milk protein, (g) length gain (mm/d)/g of milk carbo-
hydrate and (h) length gain (mm/d)/g of milk lipids(28,29).
Statistical analyses
All statistical analyses were conducted using IBM® SPSS
Statistics® programme, version 22.0 (SPSS Inc.). Shapiro–Wilk
and Kolmogorov–Smirnov tests, as well as visual inspection of
histograms, were applied for all variables in the three study
groups to check them for normality. Variables with normal dis-
tribution were presented as means and standard deviations,
while non-normally distributed variables as median and inter-
quartile range. Categorical variables were expressed as frequen-
cies and percentages. Differences among BF, SF and EF groups
were tested using ANOVA or Welch and Student t test for two
groups, Kruskal–Wallis rank sum test for non-normally distrib-
uted variables, and χ2 or Fisher’s exact tests for categorical var-
iables were used depending on the response variable.
Interaction test betweenweight GV up to 6months and the study
groups was performed to identify effects on infant’s growth.
Relevant confounders (maternal age, height and IQ) were
included in the ANCOVA and in the adjusted multivariate
ANCOVA. Bonferroni corrected post hoc comparisons were used
to identify significant group differences in pairs. P< 0·05 values
were considered statistically significant.
Sample size was calculated before the beginning of the
COGNIS study, as previously described(41). Statistical power
was calculated for the present study applying the following
equation(42):





Background characteristics and baseline data of parents and
infants participating in the COGNIS study are shown in Table 1.
There were statistically significant differences between study
groups with respect to maternal age, height and IQ. Mothers of
BF infants were older and taller than mothers of EF infants
(P= 0·028 and 0·005, respectively). These variables (maternal
age and height) were included as confounders in further growth
patterns statistical analyses. Furthermore, mothers of BF group
showed higher IQ compared with the mothers of the formula
fed groups (SF and EF) (P< 0·001); thus, IQ was also included
as a confounder since it was identified as a variable that may
be directly or indirectly related to growth and development and
the type of feeding in infants(12,43).
Regarding newborn’s characteristics, no differences were
found between study groups in anthropometrics parameters at
birth, including weight, length, HC and their respective z-scores
by age (WAZ, WLZ, LAZ, BMI-for-age z-score and HCZ). Breast-
feeding days were significantly different between the three study
groups (P< 0·001) due to the design of the COGNIS study.
Effects of the type of feeding on anthropometric
characteristics and daily growth gain in infants during
their first 18 months of life
Results concerning infants’ anthropometric measures are shown
in Table 2. HC at 4 and 6 months was bigger in the formula fed
groups compared with the BF infants in the confounders (mater-
nal age, height and IQ) adjusted model (Padj= 0·013; Padj= 0·004,
respectively). HCZwas also significantly higher at 4 and 6 months
in the formula fed infants in comparison with those in the BF
group (Padj= 0·018; Padj= 0·008, respectively). Moreover, length
at 12 months of age was higher in the SF group than in the BF
group (Padj= 0·041) (Table 2). No significant differences were
found in WAZ, WLZ, LAZ and BMI-for-age z-score along the
COGNIS groups.
In order to estimate GV in COGNIS infants, we next evaluate
weight, length and HC gains in three time intervals: (i) up to
6 months, (ii) between 6 and 12 months and (iii) between 12
and 18 months (Table 3). Infants from the formula fed groups
(SF or EF) had significantly higher length gain (cm/d)
(Padj = 0·015) and lowerHC gain (cm/d) (Padj= 0·001) compared
with the BF infants at 6 months of age. Between 6 and 12months
of age, the SF group presented a significantly lower HC gain
compared with BF infants (Padj = 0·019) (Table 3).
Growth velocity and catch-up growth
Infants’ GV and catch-up indicators were classified as slow, nor-
mal or rapid according to the aforementioned criteria in the
‘Methods’ section. At 6 months, the SF group showed a lower
proportion of slow length GV when compared with the BF
infants (P= 0·028). Formula fed infants showed higher propor-
tion of slow, and lower proportion of rapid HC GV compared
with the BF infants (P< 0·001) (Table 4). When analysing the
WAZ catch-up until 6 months of life, the formula fed groups
(SF or EF) had significantly lower percentage of slow and higher
percentage of rapid catch-up growth compared with the BF
group (P< 0·001). Regarding WLZ catch-up until 6 months of
life, EF and BF groups are characterised by higher proportion
of normal catch-up growth compared with the SF group,
although not reaching significant difference. On the other hand,
the SF group showed a lower percentage of infants classified as
slow catch-up growth (P= 0·046). No significant differences
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Table 1. Parents and infants baseline characteristics by study group
SF EF BF
Mean SD n % Median Range Mean SD n % Median Range Mean SD n % Median Range P**
Maternal age (years)* 30·51 6·74a,b 30·10 5·99a 32·94 5·38b 0·028
Pre-conceptional maternal BMI (kg/m2)† 24·18 21·75–27·61 23·68 21·14–27·30 23·90 21·80–26·16 0·842
Maternal height (m)* 1·61 0·06a,b 1·60 0·06a 1·63 0·06b 0·005
Maternal IQ (points)* 101·29 15·51a 97·47 16·02a 108·90 14·22b < 0·001
Smoking during pregnancy‡ 13 18·84 10 12·99 2 4·65 0·098
Weight gain during pregnancy (kg)† 7 3·5–10 6 3–9·50 6 4–9 0·781
Type of delivery‡
Vaginal 62 72·94 60 70·59 37 74·00 0·899
Caesarean 23 27·06 25 29·41 13 26·00
Siblings (≥ 1)‡ 52 61·20 43 50·60 22 44·00 0·128
Paternal age (years)* 32·68 6·89 33·31 7·03 35·07 5·01 0·134
Paternal BMI (kg/m2)† 27·65 24·55–30·48 26·95 24·75–29·63 27·25 24·60–29·63 0·950
Paternal height (m)* 1·74 0·06 1·73 0·06 1·75 0·07 0·436
Paternal IQ (points)† 108 96–117 102 92–111 108 99–117 0·062
Place of residence‡
Urban 38 44·71 28 32·94 15 30·00 0·148
Rural 47 55·29 57 67·06 35 70·00
Newborn characteristics
Gestational age at birth (weeks)† 40 38–40 40 39–40 39·50 38–40·25 0·925
Sex‡
Boy 49 57·65 51 60·00 21 42·00 0·105
Girl 36 42·35 34 40·00 29 58·00
Birth weight (g)* 3266·25 459·08 3347·76 486·41 3321·20 431·73 0·513
Birth length (cm)† 50 49–52 51 49–52 51 49–51·25 0·431
Birth head circumference (cm)† 35 34–35·5 34·25 34–35 35 33·25–35 0·481
Birth WAZ (z-score)* –0·11 0·98 0·11 0·95 0·05 0·88 0·320
Birth WLZ (z-score)* –0·67 1·06 –0·66 1·02 –0·62 1·08 0·972
Birth LAZ (z-score)† 0·46 −0·08–1·12 0·92 0·06–1·53 0·59 –0·08–1·02 0·247
Birth BAZ (z-score)* –0·48 1·00 –0·36 1·00 –0·41 1·00 0·667
Birth HCZ (z-score)* 0·38 1·05 0·21 0·93 0·25 0·99 0·581
Breast-feeding (d)† 8 0–21 7 1–25 420 270–540 < 0·001
SF, standard infant formula; EF, experimental infant formula; BF, breastfed infants; IQ, intelligence quotient; WAZ, weight-for-age z-score; WLZ, weight-for-length z-score; LAZ, length-for-age z-score; BAZ, BMI-for-age z-score; HCZ, head circumference-for-age z-score.
* Mean values and standard deviations; † medians and interquartile ranges; ‡ numbers and percentages.
** P-values for overall differences betweenCOGNIS-groups. ANOVA for normally distributed variables, Kruskal–Wallis rank-sum test for non-normal continuous variables, and χ2 test for categorical variables. Valueswhich do not share the same suffix (ab) were significantly
different in Bonferroni post hoc test. Bold: P-value< 0·05.
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Table 2. Effect of the type of feeding on anthropometric data in infants during the first 18 months of life.
2 months 3 months 4 months 6 months 12 months 18 months
Mean SD P* Padj* Mean SD P* Padj* Mean SD P* Padj* Mean SD P* Padj* Mean SD P* Padj* Mean SD P* Padj*
Weight (kg) SF 5·19 0·65 0·894 0·814 6·02 0·75 0·966 0·936 6·74 0·84 0·851 0·255 7·89 0·93 0·092 0·078 9·94 1·16 0·230 0·271 11·22 1·21 0·459 0·566
EF 5·19 0·67 6·00 0·76 6·76 0·86 7·77 0·95 9·80 1·20 11·26 1·22
BF 5·27 0·68 6·06 0·78 6·47 0·80 7·45 0·97 9·53 1·23 10·98 1·25
Length (cm) SF 56·54 2·19 0·819 0·886 59·62 2·29 0·873 0·897 62·45 2·28 0·297 0·564 66·43 2·27 0·078 0·064 75·12 2·64a 0·069 0·041 81·24 2·99 0·252 0·454
EF 56·47 2·22 59·62 2·31 62·08 2·34 66·12 2·33 74·48 2·75a,b 81·52 3·02
BF 56·31 2·27 59·84 2·37 62·04 2·17 65·31 2·38 73·63 2·81b 80·69 3·08
BMI (kg/m2) SF 16·20 1·44 0·507 0·445 16·91 1·55 0·989 0·958 17·25 1·58 0·123 0·133 17·86 1·60 0·457 0·409 17·61 1·54 0·985 0·973 17·00 1·24 0·860 0·815
EF 16·22 1·47 16·83 1·57 17·49 1·62 17·73 1·64 17·62 1·60 16·88 1·25
BF 16·58 1·49 16·87 1·61 16·79 1·50 17·42 1·67 17·54 1·63 16·83 1·28
HC (cm) SF 39·28 1·25 0·114 0·107 40·57 1·28 0·178 0·123 41·75 1·30a 0·330 0·013 43·65 1·28a 0·005 0·004 46·39 1·42 0·325 0·514 47·52 1·42 0·324 0·423
EF 39·22 1·25 40·62 1·30 41·79 1·34a 43·62 1·31a 46·37 1·48 47·83 1·44
BF 38·72 1·28 40·06 1·33 40·99 1·24b 42·82 1·34b 46·05 1·51 47·49 1·47
WAZ SF –0·43 0·87 0·589 0·718 –0·30 0·91 0·640 0·754 –0·15 0·95 0·719 0·582 0·15 0·96 0·358 0·180 0·44 1·01 0·405 0·440 0·38 0·91 0·839 0·756
EF –0·38 0·89 –0·36 0·92 –0·13 0·97 0·03 0·98 0·28 1·02 0·34 0·92
BF –0·28 0·90 –0·21 0·94 –0·32 0·86 –0·22 1·00 0·17 1·04 0·23 0·94
WLZ SF 0·43 1·05 0·393 0·354 0·34 1·04 0·926 0·916 0·26 1·02 0·132 0·160 0·52 1·01 0·625 0·544 0·63 1·03 0·903 0·945 0·65 0·87 0·948 0·900
EF 0·46 1·07 0·26 1·05 0·44 1·04 0·42 1·04 0·57 1·06 0·59 0·88
BF 0·75 1·09 0·32 1·08 0·03 0·92 0·28 1·06 0·58 1·07 0·56 0·90
LAZ SF –0·79 0·99 0·896 0·821 –0·66 0·95 0·536 0·736 –0·44 0·95 0·512 0·575 –0·28 0·93 0·452 0·225 –0·06 1·04 0·125 0·083 –0·22 1·00 0·574 0·642
EF –0·74 1·00 –0·68 0·97 –0·60 0·96 –0·36 0·96 –0·30 1·06 –0·20 1·00
BF –0·87 1·02 –0·52 0·99 –0·43 0·85 –0·61 0·97 –0·57 1·07 –0·40 1·03
BAZ SF 0·01 0·95 0·338 0·373 0·11 1·01 0·916 0·903 0·14 1·02 0·170 0·181 0·42 1·03 0·620 0·526 0·65 1·04 0·885 0·967 0·72 0·85 0·900 0·921
EF 0·05 0·96 0·04 1·02 0·29 1·03 0·32 1·05 0·62 1·06 0·65 0·86
BF 0·29 0·98 0·12 1·05 –0·10 0·92 0·18 1·08 0·68 1·08 0·66 0·88
HCZ SF 0·34 0·87 0·163 0·054 0·30 0·87 0·332 0·091 0·36 0·87a 0·107 0·018 0·57 0·84a 0·044 0·008 0·57 0·92 0·621 0·420 0·44 0·90 0·469 0·512
EF 0·34 0·87 0·32 0·87 0·41 0·88a 0·58 0·86a 0·62 0·94 0·64 0·91
BF –0·08 0·89 –0·07 0·89 –0·08 0·78b 0·07 0·88b 0·36 0·96 0·49 0·92
SF, standard infant formula; EF, experimental infant formula; BF, breastfed infants; HC, head circumference; WAZ, weight-for-age z-score; WLZ, weight-for-length z-score; LAZ, length-for-age z-score; BAZ, BMI-for-age z-score; HCZ, head
circumference-for-age z-score; IQ, intelligence quotient.
* P-value was obtained from ANOVA; Padj was obtained from ANOVA; Padj was obtained from ANCOVA for the group differences using univariate general linear model, including the effects from the following potential confounders: maternal
age, height and IQ. Bold: P-value< 0·05.
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were detected in theGV and catch-up growth parameters at 6–12
and 12–18 months of age (Table 4).
Growth patterns in COGNIS infants up to 18 months
Regarding interaction between GV up to 6 months and study
groups (SF, EF and BF), no statistically significant results were
detected in those test (P-values >0·05) (online Supplementary
Table S2). This means that there is no effect of the study group
in those growth parameters and indicators evaluated. Same hap-
pens to interaction between weight GV and study group. Only
one factor has effect on growth: GV up to 6 months of age
(P< 0·05), which indicates that this factor may predict sub-
sequent growth trajectory while diet group does not.
However, due to the study design, results are presented accord-
ing to study group.
Growth patterns were evaluated up to 18 months of age
according to the classification of weight GV up to 6 months of
age visits (Fig. 2(a)–(g) and online Supplementary Table S3).
Infants with slow growth velocity. At 6 months of age, LAZ
was significantly lower in the SF group (–2·27 (SD 0·59)) com-
pared with the BF group (–0·45 (SD 0·65)) (Padj= 0·036) (Fig.
2(e)), although the signification did not remain at later ages.
Infants with normal growth velocity. At 6months, weight (kg)
was significantly higher in the SF infants (7·56 (SD 0·60)) com-
pared with the BF group (7·11 (SD 0·61)) (Padj = 0·025) (Fig.
2(a)); length (cm) was significantly higher in the SF group com-
pared with the BF group (SF: 66·24 (SD 1·84); BF: 64·95 (SD 1·90);
Padj= 0·041) (Fig. 2(b)), while HC (cm) was significantly higher
in the EF group comparedwith the BF group (EF: 43·76 (SD 1·17);
BF: 42·63 (SD 1·17); Padj= 0·008) (Fig. 2(c)). Similarly, at 18
months of age, the EF group presented higher HC (cm) com-
pared with the SF group (EF: 48·08 (SD 1·34); SF:
47·14 (SD 1·30); Padj= 0·031) (Fig. 2(c)).
Regarding growth z-scores, at 6 months, HCZ was signifi-
cantly higher in the EF group compared with the BF group
(EF: 0·63 (SD 0·80); BF: 0·00 (SD 0·80); Padj= 0·034) (Fig. 2(g)).
And at 18 months, HCZ was higher in the EF group compared
with the SF group (EF: 0·74 (SD 0·85); SF: 0·17 (SD 0·82);
Padj= 0·038) (Fig. 2(g)).
Infants with rapid growth velocity. Up to 18 months, no
differences in weight, length or HC, nor WAZ, LAZ, WLZ or
HCZ were found according to the feeding group (Fig. 2(a)–(g)
and online Supplementary Table S3).
Energetic efficiency
EE was estimated up to 18 months of age according to energy
and macronutrients intake per day from breast milk or infant for-
mula (Fig. 3). For this purpose, we first evaluated if there were
differences in infant formula/breast milk volume intake per day
(d) at 6, 12 and 18months. We found that themilk volume intake
(ml/d) was significantly different between the study groups at 6
months of age (SF: 683·59 (SD 255·88); EF: 696·19 (SD 217·29);
BF: 843·18 (SD 242·37), P= 0·003); thus, this parameter (milk vol-
ume intake) was included as an additional confounder for fur-
ther EE analysis.
Energetic efficiency and weight gain (g/d). Weight gain/g of
milk protein at 6, 12 and 18months of agewas significantly lower
in the formula fed groups (SF or EF) comparedwith the BF group
(6 months, Padj= 0·003; 12 months, Padj< 0·001; 18 months,
Padj< 0·001) (Fig. 3(a) and online Supplementary Table S4).
Conversely, weight gain/g of milk lipids was significantly higher
in the infant formula groups compared with the BF infants (6
months, Padj< 0·001; 12 months, Padj < 0·001; 18 months,
Padj= 0·007) (Fig. 3(b) and online Supplementary Table S4).
Furthermore, weight gain/418·4 kJ (100 kcal) of milk was signifi-
cantly higher in the SF group compared with the BF infants at 12
months of age (Padj= 0·049). However, at 6 and 18months of age
therewere no significant differences. Regardingweight gain/g of
milk carbohydrates, there were no significant differences
between feeding groups up to 18 months (online
Supplementary Table S4).
Table 3. Daily growth gain in infants of the COGNIS study.
Up to 6
months† 6–12 months 12–18 months
Mean SD P* Padj* Mean SD P* Padj* Mean SD P* Padj*
Weight gain (g/d) SF 24·17 4·72 0·184 0·215 11·29 2·95 0·999 1·000 7·26 2·49 0·882 0·986
EF 24·23 4·81 11·27 3·02 7·34 2·51
BF 22·20 4·91 11·28 3·06 7·29 2·56
Length gain (cm/d) SF 0·09 0·02a 0·008 0·015 0·05 0·01 0·137 0·136 0·03 0·01 0·062 0·069
EF 0·09 0·02a 0·05 0·01 0·04 0·01
BF 0·08 0·01b 0·05 0·01 0·04 0·01
HC gain (cm/d) SF 0·04 0·01a < 0·001 0·001 0·02 0·00a 0·023 0·019 0·01 0·00 0·080 0·139
EF 0·04 0·01a 0·02 0·00a,b 0·01 0·00
BF 0·05 0·01b 0·02 0·00b 0·01 0·00
SF, standard infant formula; EF, experimental infant formula; BF, breastfed infants; HC, head circumference; IQ, intelligence quotient.
* P-value was obtained from ANOVA; Padj was obtained by ANCOVA for the group differences using univariate general linear model, including the effects of the following potential
confounders: maternal age, height and IQ. Bold: P-value< 0·05.
† Calculated from the baseline visit (formula fed infants group) or from birth to 6 months of life (breastfed infants). Data were analysed using the WHO growth velocity standards, and
presented as 6-month increments from birth to 18 months and stratified by sex(38).
a,b Values not sharing the same suffix were significantly different in Bonferroni post hoc test.
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Table 4 Growth velocity and catch-up growth in infants during the first 18 months of life by COGNIS study groups.
Up to 6 months† 6–12 months 12–18 months
SF EF BF SF EF BF SF EF BF
n % n % n % P* n % n % n % P* n % n % n % P*
Weight growth velocity Slow 4 6·67 10 14·49 3 7·50 0·530 0 0·00 2 3·17 0 0·00 0·786 7 14·58 3 5·36 3 8·11 0·386
Normal 37 61·66 35 50·73 24 60·00 27 52·94 30 47·62 20 52·63 28 58·34 42 75·00 25 67·57
Rapid 19 31·67 24 34·78 13 32·50 24 47·06 31 49·21 18 47·37 13 27·08 11 19·64 9 24·32
Length growth velocity Slow 8 13·33a 14 20·29a,b 15 37·50b 0·028 3 5·88 3 4·76 2 5·36 0·119 8 16·67 4 7·14 7 18·92 0·139
Normal 37 61·67 36 52·17 21 52·50 17 33·33 31 49·21 23 60·53 30 62·50 29 51·79 19 51·35
Rapid 15 25·00 19 27·54 4 10·00 31 60·78 29 46·03 13 34·21 10 20·83 23 41·07 11 29·73
HC growth velocity Slow 23 38·33a 21 30·44a 2 6·25b < 0·001 4 7·85 7 11·12 2 5·27 0·115 10 20·83 7 12·50 5 13·51 0·153
Normal 32 53·34 40 57·97 16 50·00 31 60·78 28 44·44 14 36·84 31 64·59 29 51·79 20 54·05
Rapid 5 8·33a 8 11·59a 14 43·75b 16 31·37 28 44·44 22 57·89 7 14·58 20 35·71 12 32·44
WAZ
Catch-up
Slow 3 5·00a 8 11·59a 13 32·50b < 0·001 1 1·96 1 1·59 0 0·00 0·772 3 6·25 2 3·57 0 0·00 0·389
Normal 34 56·67 32 46·38 24 60·00 39 76·47 48 76·19 26 68·42 44 91·67 51 91·07 37 100·00
Rapid 23 38·33a 29 42·03a 3 7·50b 11 21·57 14 22·22 12 31·58 1 2·08 3 5·36 0 0·00
WLZ
Catch-up
Slow 11 18·33a 15 21·74a,b 16 41·02b 0·046 7 13·73 8 12·70 3 7·89 0·211 7 14·58 7 12·50 4 10·81 0·672
Normal 32 53·34 34 49·28 19 48·72 38 74·51 39 61·90 23 60·53 38 79·17 43 76·79 32 86·49
Rapid 17 28·33 20 28·98 4 10·26 6 11·76 16 25·40 12 31·58 3 6·25 6 10·71 1 2·70
SF, standard infant formula; EF, experimental infant formula; BF, breastfed infants; HC, head circumference; WAZ, weight-for-age z-score; WLZ, weight-for-length z-score.
* χ2 test for categorical variables. P-values are comparisons between the COGNIS-groups. Values which do not share the same suffix (a,b) are significantly different in Bonferroni post hoc test. Bold: P-value< 0·05. Growth velocity was
classified as: slow: < −1 SD, normal: ≥−1 SD and ≤þ 1 SD or rapid: >þ 1 SD; catch-up growth classified as follows: slow: <−0·67, normal: ≥−0·67 and ≤þ 0·67 and rapid: >þ 0·67 (see ‘Methods’ section for more details).
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Fig. 2. Growth patterns up to 18 months of life, according to weight growth velocity up to 6 months of life by feeding group. Data are marginal mean values and standard
deviations. Padj was obtained by ANCOVA for the group differences using univariate general linear model, including the effects of the following potential confounders:
maternal age, height and IQ. *Padj-values < 0·05 and **Padj-values< 0·01. SGV, slow growth velocity; NGV, normal growth velocity; RGV, rapid growth velocity; SF,
standard infant formula; EF, experimental infant formula; BF, breastfed infants; HC, head circumference; WAZ, weight-for-age z-score; LAZ, length-for-age z-score;
WLZ, weight-for-length z-score; HCZ, head circumference-for-age z-score; IQ: intelligence quotient. Dotted lines indicate normal growth according to WHO cut-off
points(37). , SF; , BF; , EF.
Fig. 3. Energetic efficiency analysis up to 18 months of age by feeding group. Data are marginal mean values and standard deviations. P-values were obtained by
multivariate ANCOVA for group differences using multivariate general linear model, including the following confounders: maternal age, height and IQ. At 6 months
of age, analysis was additionally adjusted by volume intake (ml/d) of infant formula or breast milk. For variables weight gain g/g protein; weight gain g/g lipids and length
gain mm/g protein at 12 months of age, and length gain mm/g lipids at 6 and 12 months of age, Padj corresponds to log-transformed for these variables. *Padj-values
< 0·05; ** Padj-values < 0·01 and *** Padj-values< 0·001. SF, standard infant formula; EF, experimental infant formula; BF, breastfed infants; IQ, intelligence quotient.
, SF; , EF; , BF.
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Energetic efficiency and length gain (mm/d). In a similar way,
there were no significant differences up to 18 months of age in
length gain/418·4 kJ (100 kcal) of milk and length gain/g of milk
carbohydrates according to the feeding group (online
Supplementary Table S4). However, at 6 months of age, length
gain/g of milk protein was lower in the SF group compared with
the BF infants (Padj = 0·023); moreover, at 12 and 18 months of
age, the formula fed groups showed lower length gain/g of
milk protein than the BF group (12 months, Padj< 0·001 and
18 months, Padj< 0·001) (Fig. 3(c) and online Supplementary
Table S4). Finally, we found that, at 12 months of age, length
gain/g of milk lipids was higher in the infant formula groups
compared with the BF group (Padj < 0·001), while at 18 months
of age it was higher in SF infants compared with the BF infants
(Padj = 0·002) (Fig. 3(d) and online Supplementary Table S4).
Discussion
The present study was aimed to perform an exhaustive analysis
of growth patterns up to 18 months of life in COGNIS infants fed
with a new bioactive compounds-enriched infant formula, com-
pared with a standard infant formula and BF infants.
Additionally, EE of infant formulas and breast milk was esti-
mated. Our results suggest that the type of feeding during the first
6 months of life may determine infant growth patterns; length
gain was higher and HC gain was lower in infants from the for-
mula fed groups (SF or EF) compared with the BF infants. These
significant differenceswere not found at 6–12 and 12–18months.
Moreover, the analysis of weight/length catch-up until 6 months
of life suggested that EF and BF groups are characterised by
higher proportion of normal catch-up growth compared with
the SF group. Studies refer that HC may be associated with spe-
cific aspects of child development in healthy population(44,45).
Also, higher HC in infants at 4 and 6 months of age might be
related to a better visual acuity at 12 months of life(41) and lan-
guage development at 4 years old in those children fed with
the enriched bioactive nutrients infant formula(46).
In general, growth is a result of a process depending on the
availability of essential nutrients. A harmonious growth results from
weight and length gains in appropriate proportion; an imbalance in
weight gain might affect linear growth and could negatively impact
on cognitive development at later ages(47). Some studies suggest to
analyse weight gain rates and linear growth as independent factors
that could affect health and development in adulthood(48,49).
Therefore, infant weight gain is generally known as the primary
indicator of healthy growth; higher weight gains between 3 and
12 months of age(50–52) have been related to higher risk of obesity
and other metabolic disorders(53,54).
Growth patterns in infants during the first months of life are a
topic of interest in paediatric research; growth characteristics have
been described according to the type of feeding in early stages of
life, given biological dynamics of humanmilk comparedwith infant
formulas(6,55,56). Results from the present study showed that the SF
fed group was characterised by a lower proportion of infants with
slowGV in length comparedwith the BF infants. In addition, when
analysing the weight/age catch-up until 6 months of life, the for-
mula fed groups (SF or EF) had significantly lower percentage of
slow growth infants compared with the BF group; conversely,
the BF group had lower proportion of rapid WAZ catch-up.
Moreover, the EF and BF groups are characterised by higher pro-
portion of normalWLZ catch-up growth comparedwith the SF one.
Research refers that infant formula intake is a risk factor for self-
regulation satiety alteration(57), higher length gain(29), higher weight
gain, rapid weight gain velocity, higher WAZ(58,59) and weight
excess at later ages(60,61) comparedwith theBF infants. Since several
years ago, infant formulas have been modified and enriched with
bioactive nutrients trying to mimic those present in human milk to
satisfy an optimal development and growth, providing the neces-
sary amount of energy and nutrients(13,16). Some studies have
reported that infant formula intake implies an elevated protein
intake, leading to increased secretion of insulin, insulin-like growth
factor type 1 and adipogenic activity(62,63); these mechanisms could
be involved in growth patterns observed in formula fed infants; in
this regard, infants fed with low protein content formulas show less
risk for obesity during childhood(27). Infant formulas tested in the
present study follow the guidelines of the ESPGHAN Committee
on Nutrition(64) and international and national recommendations
for infant formula composition, and their protein content is within
theminimum recommended range. Results froma studywith a sim-
ilar design to the present one indicated a rapid GV in formula fed
infants compared with the breastfed ones, with no differences
between standard formula or milk fat globule membrane supple-
mented formula(18).
The present study also evaluated whether differences in
growth patterns between types of feeding with infant formula
(SF or EF) or breast-feeding in the COGNIS study could be
related to the EE of macronutrients present in infant formula
and breast milk as a possible, and partial, explanation of the
results obtained. To date, and despite that EE of infant formulas
has been described, studies are largely based on short-term
infant growth follow-up (until 6 months of life), and there is
insufficient evidence to accurately compare EE in infant formula
and breast milk(29,65). The present study reports information
about EE up to 18 months of age in formula fed and BF infants.
Our data showed that BF infants had higher weight and length
gain per g of milk protein compared with the formula fed infants
up to 18months of life, whilemilk lipids appear to be responsible
for increased weight and length gain in those infants who
received infant formula. These findings may be related to the
nutritional composition of breast milk; in fact, breast milk pro-
vides high biological value proteins, optimal whey/casein ratio
and adequate supply of amino acids(66–69). Despite its higher
content in lipids, breast milk also contains enzymes needed
for digestibility and utilisation of fatty acids(70). Both nutritional
characteristics, together with its content in bioactive nutrients,
hormonal and immune factors, could determine a better EE of
breast milk compared with infant formulas in order to ensure
an optimal infant growth and development. It is important to
note that data from the present study cannot be attributed to a
single specific component of infant formulas (enriched or
not), but as a whole product designed to meet infant nutritional
needs; moreover, there is likely a synergy among the different
bioactive components, which could be associated with bioavail-
ability and biological utilisation of nutrients. Currently, there is
insufficient evidence to support the effect of DHA and
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arachidonic acid enriched formula on growth and adipos-
ity(30,71,72), or synbiotic supplementation on infants
growth(23,30,73,74). Effects on immune system and on microbiota
structure and function have been described; thesemay be factors
influencing children growth as well(23,73,74). Thus, data obtained
may be useful to develop further strategies not only focused on
narrowing the nutritional gap but also the functional and meta-
bolic gap, between infant formulas and human milk.
One of the strengths of the present study relies on long-term
infant growth follow-up, as consequence of the longitudinal
design of the COGNIS study, thus allowing a cross-sectional
analyses of infant growth until 18 months of life, compared with
other studies with shorter follow-up. Secondly, despite partici-
pants dropout at 18 months of life, statistical power was calcu-
lated to identify the validity of the results found in the present
study. Statistical power reached to detect a minimum difference
of 0·6 SD in growth patternswas 80 % at 18months of age, enough
to detect relevant differences in growth patterns between study
groups. Additionally, it is also important to highlight that 26 % of
infants in the control group continued breast-feeding until 18
months, which allowed to estimate the EE and compare growth
patterns between infants who received SF or EF (initiation and
follow-on formulas), and those whowere breastfed at long-term.
Finally, COGNIS design also included data about socio-demo-
graphic and anthropometric characteristics both from parents
and newborns, which were used as potential confounders in
statistical models.
Research about infant growth has been largely focused on the
analysis of growth in a transversal way (z-scores). Despite infant
weight assessment is considered a global indicator of healthy
child growth, our results suggest that it could beworth to analyse
in depth how theweight GV and trajectorymodify the length and
HC, as well as the growth indicators (WAZ, LAZ, WLZ and HCZ)
during childhood. Current results have an added value due to the
methodology used, based on different techniques with z-scores
trajectories, GV using the WHO growth standards and classifica-
tion according to growth rate (catch-up) between follow-up vis-
its. Thus, this methodology could provide a basis to evaluate
long-term potential impact of type of feeding at early age on
infant GV and trajectory. Moreover, it can be useful to provide
detailed and individualised guidelines for the introduction of
complementary feeding, according to nutritional needs and
infant growth patterns (especially for those who present rapid
or slow growth trajectories), ensuring an adequate and normal
growth for age.
However, there are limitations that must be acknowledged.
First, due to ethical reasons, breastmilkmust be offered on demand
with no limits in its volume or duration. Consequently, volumes of
breastmilk intakewere obtained from 3-d dietary records aswell as
theoretical estimates based on previously published findings(39,40).
For future studies, we suggest to weight the infant before and after
being breastfed to know more accurately breast milk volume
intake. Second, breast milk is a nutrient with a varying nutritional
composition, both in a time-day basis and over time, to adapt to
infants nutritional needs. Our study has not an individual analysis
of the breast milk of each infant during the follow-up; therefore,
composition in the present study was estimated based on a full
mature breast milk composition as reported in the USDA
National Nutrient Database for Standard Reference(66). It would
be interesting in later studies to analyse the composition of
breast milk individually and describe the composition
of nutrients during the first 2 years of age. Third, our goal
was to estimate EE of infant formulas (SF or EF) and breast milk,
and we did not include complementary feeding in the analysis
performed; thus, it would be interesting to analyse the com-
plementary feeding in the three COGNIS groups in future stud-
ies. Finally, as previously reported(41), COGNIS study design
implies the non-randomisation of the BF group, in contrast to
both SF and EF groups, which could explain differences in
maternal age, height and IQ baseline characteristics.
In summary, herewith we suggest that type of feeding
received between birth and the first 6 months of life could be
responsible for differences in infant GV and catch-up growth.
GV during first 6 months, which may be influenced by feeding,
seems to be the main predictor of subsequent growth patterns.
Moreover, in infants fed with the enriched bioactive nutrients
formula, higher HC at 6 months of age was found in the present
study, which could be related to better visual acuity(41) and lan-
guage development at 4 years old(46), as previously reported. EE
of breastmilk nutrients seems to be responsible for its benefits on
infant growth. Our results suggest that traditional methodology
used for growth analysis may be insufficient to characterise the
growth trajectory during childhood. In fact, traditional method-
ology is based on the parameters and indicators in a cross-
sectional way, but not on an evolutionary one. However, analy-
sis ofweight, length andHC gains as a function of time and veloc-
ity, and how the GV changes, may better define the growth
pattern at later stages. Further research based on long-term
growth monitoring is necessary to establish the effects of early
nutrition (infant formula fed or breast milk and complementary
feeding) on body composition as an indicator of metabolic long-
term health risks, and children’s growth later in life.
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